DDInter1855 DDInter782
Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.[L8246,L8249,L8252,L8255,L8258,L8261,L8264] Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular
In April 2018, the U.S. Food and Drug Administration (FDA) and the Swiss company Helsinn approved the intravenous formulation of AKYNZEO® (NEPA, a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) as an alternative treatment option for patients experiencing chemotherapy-induced nausea and vomiting . Fosnetupitant is the pro-drug form of netupitant [FDA label]. Generally, 25% to 30% of patients with a diagnosis of cancer receive chemotherapy as a treatment modality and 70% to 80% of these patients undergoing chemotherapy treatment may experience nausea and vomiting as major side effects. Considered one of the most distressing side effects of chemotherapy, nausea and vomiting has an immense impact on the quality of life of patients receiving certain antineoplastic therapies .
Triamcinolone {u} (Compound) resembles {v} (Compound) Prednisone
Triamcinolone {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Fluoxymesterone
Triamcinolone {u} (Compound) resembles {v} (Compound) Budesonide
Triamcinolone {u} (Compound) treats {v} (Disease) multiple sclerosis
Triamcinolone {u} (Compound) binds {v} (Gene) SERPINA6
Triamcinolone {u} (Compound) upregulates {v} (Gene) CDKN1A
Triamcinolone {u} (Compound) palliates {v} (Disease) brain cancer
Triamcinolone {u} (Compound) is included by {v} (Pharmacologic Class) Corticosteroid Hormone Receptor Agonists
Triamcinolone {u} (Compound) downregulates {v} (Gene) GDF15
Triamcinolone {u} (Compound) causes {v} (Side Effect) Acute coronary syndrome
Triamcinolone (Compound) resembles Prednisone (Compound)
Triamcinolone may cause a moderate interaction that could exacerbate diseases when taken with Fluoxymesterone
Triamcinolone (Compound) resembles Budesonide (Compound)
Triamcinolone (Compound) treats multiple sclerosis (Disease)
Triamcinolone (Compound) binds SERPINA6 (Gene)
Triamcinolone (Compound) upregulates CDKN1A (Gene)
Triamcinolone (Compound) palliates brain cancer (Disease)
Triamcinolone (Compound) is included by Corticosteroid Hormone Receptor Agonists (Pharmacologic Class)
Triamcinolone (Compound) downregulates GDF15 (Gene)
Triamcinolone (Compound) causes Acute coronary syndrome (Side Effect)